Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology
Second Session, Forty-first Parliament, 2013-14
Chair: The Honourable KELVIN KENNETH OGILVIE
Wednesday, January 29, 2014
Thursday, January 30, 2014
Issue No. 4
Second and third meetings on:
Study on prescription pharmaceuticals in Canada
INCLUDING:
THE FIFTH REPORT OF THE COMMITTEE
(Interim Report:
Prescription Pharmaceuticals in Canada: Off-Label Use
WITNESSES
Wednesday, January 29, 2014
Health Council of Canada:
Dr. Ingrid Sketris, Councillor.
Canadian Canadian Patient Safety Institute:
Hugh MacLeod, Chief Executive Officer;
Emily Musing, Board Member.
Thursday, January 30, 2014
Canadian Institute for Health Information:
John Wright, President and CEO;
Michael Gaucher, Director, Pharmaceuticals and Health Workforce Information Services.
Canadian Agency for Drugs and Technologies in Health:
Brian O'Rourke, President and CEO.
MEMBERS OF THE COMMITTEE
The Honourable Kelvin Kenneth Ogilvie, Chair
The Honourable Art Eggleton, P.C., Deputy Chair
and
The Honourable Senators:
Buth, *Carignan, P.C. (or Martin), Chaput, Cordy, *Cowan (or Fraser), Dyck, Eaton, Enverga , Segal, Seidman, Seth, Stewart Olsen
* Ex officio members
(Quorum 4)
Changes in membership of the committee:
Pursuant to rule 12-5, membership of the committee was amended as follows:
The Honourable Senator Buth replaced the Honourable Senator Bellemare (January 29, 2014).
The Honourable Senator Eaton replaced the Honourable Senator Tannas (January 29, 2014).
The Honourable Senator Tannas replaced the Honourable Senator Eaton (January 29, 2014).